4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-013984
Chief Financial Officer gave up 13,237 shares (to pay taxes)
- Chief Financial Officer acquired 33,983 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCombe William D. Chief Financial Officer | 2025-05-19 | Option exercise | +25,283 | 25,283 | D | ||
| McCombe William D. Chief Financial Officer | 2025-05-19 | Shares withheld for taxes | −9,848 | $2.69 | $26,491 | 15,435 | D |
| McCombe William D. Chief Financial Officer | 2025-05-19 | Option exercise | +8,700 | 24,135 | D | ||
| McCombe William D. Chief Financial Officer | 2025-05-19 | Shares withheld for taxes | −3,389 | $2.69 | $9,116 | 20,746 | D |
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2025-05-19 | Option exercise · Restricted Stock Units | −25,283 | 75,849 | D | ||
| McCombe William D. Chief Financial Officer | 2025-05-19 | Option exercise · Restricted Stock Units | −8,700 | 200,116 | D | ||
Loading xslF345X05/form4-05212025_090504.xml…